共找到 2 份报告搜索:抗菌药物创新

The need for European countries to complement EU-level pull incentives with national provisions for novel antimicrobials

Charles River Associates2026-07-0223

Changing carbapenemase distribution in Klebsiella pneumoniae and Escherichia coli in the EU/EEA – preliminary results from the main collection of the CRE25 survey

European Centre for Disease Prevention and Control (ECDC)2026-07-116